Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Commerce Health Ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 2
Lead investments 0
Exits 1
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Health Diagnostics
  • Pharmaceuticals

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Commerce Health Ventures:
Typical Co-investors
Commerce Health Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Commerce Health Ventures:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
1apeiron Florida, Miami, United States
3D Capital Partners -
Autobio Diagnostics China, Henan, Zhengzhou
Avalis -
Avison Young Canada, Ontario, Toronto
Commercial Drone Fund California, San Francisco, United States
Cornerstone Equity Investors Connecticut, Stamford, United States
First Imagine! Ventures England, London, United Kingdom
Haoshi Touzi China, Shanghai
Hongjian Qiye Guanli China, Shanghai
Hopstech -
Lead Capital Management Chiyoda, Japan
North-East Family Office Denmark, Hellerup, Hovedstaden
Pivotal Investments Oregon, Portland, United States
ROUTEONE POWER Japan, Tokyo
Unlock Venture Partners Seattle, United States, Washington
VentureSpur Dallas, Texas, United States
Worthington Industries Columbus, Ohio, United States
Yixin Touzi Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

EKR Therapeutics

Biotechnology
Health Care
Pharmaceutical
Pharmaceuticals
Therapeutic Devices
Therapeutics
$5M03 Jul 2006 New Jersey, United States

Sopherion Therapeutics

Biotechnology
Health Care
Health Diagnostics
Pharmaceutical
$47M20 Sep 2004 New Jersey, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Commerce Health Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 26M
Peak activity year 2004
Lead investments 0
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

EKR Therapeutics

Biotechnology
Health Care
Pharmaceutical
Pharmaceuticals
Therapeutic Devices
Therapeutics
$5M03 Jul 2006 New Jersey, United States

Sopherion Therapeutics

Biotechnology
Health Care
Health Diagnostics
Pharmaceutical
$47M20 Sep 2004 New Jersey, United States
Crunchbase icon

Content report

The following text will be sent to our editors: